"Cladribine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia.
| Descriptor ID |
D017338
|
| MeSH Number(s) |
D03.633.100.759.590.138.300.200 D03.633.100.759.590.138.325.075 D13.570.230.229.075 D13.570.583.138.300.200 D13.570.583.138.325.075 D13.570.800.096.300.200
|
| Concept/Terms |
Cladribine- Cladribine
- 2-Chlorodeoxyadenosine
- 2-Chloro-2'-deoxyadenosine
- 2'-Deoxy-2-chloroadenosine
|
Below are MeSH descriptors whose meaning is more general than "Cladribine".
Below are MeSH descriptors whose meaning is more specific than "Cladribine".
This graph shows the total number of publications written about "Cladribine" by people in this website by year, and whether "Cladribine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cladribine" by people in Profiles.
-
A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS study. Neurodegener Dis Manag. 2023 Oct; 13(5):261-268.
-
Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study. Mult Scler. 2023 05; 29(6):719-730.